Original Research

JCP
Antipsychotic Efficacy of KarXT (Xanomeline−Trospium)
Original Research

image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ May 11, 2022

This post hoc analysis of phase 2 data evaluated rates and time course of response with the new combination oral agent KarXT (xanomeline−trospium) in the treatment of schizophrenia.
PCC
Social and Emotional Health of College Students and COVID-19
JCP
Daily Dose Effects of Risperidone on Metabolic Parameters
PCC
Resilience, Coping, Distress, and COVID-19
PCC
Psychological Morbidity Among COVID-19 Survivors
JCP
Epilepsy and Suicide Attempt
JCP
Receipt of Antidepressants and Retention in Buprenorphine Treatment for OUD
JCP
Economic Burden of PTSD in the US
PCC
Psychocutaneous Medicine in Iraq
JCP
Transdiagnostic PRS Prediction of Mood Disorders
PCC
Care Management Intervention for Noncardiac Chest Pain
JCP
Co-Occurring Depression and Response During OUD Treatment
JCP
ECT and Death by Suicide
JCP
Effects of a Digital Medicine System on Psychiatric Hospitalization Rates for Adults With Schizophrenia
JCP
Smartphone-Based Mental Health Screening in Adolescents and Young Adults
PCC
Health Anxiety and Lifestyle Behavior During COVID-19
JCP
Economic Burden of MDD and Suicidality
PCC
Early Improvement in OCD
JCP
Differences Among Second-Generation Antipsychotics in Effects on HbA1c
JCP
Association of Higher ALFF and Suicidal Ideation in BD
JCP
Increased Admissions for Substance Use Disorder Among Older Adults, 2000–2017
PCC
Stigmatization Associated With COVID-19
JCP
Treatment Resistance in Late-Onset MDD
PCC
Use of the Telugu Insomnia Severity Index During COVID-19